Summary Differentiation-inducing ability of y-radiation, N,N-dimethylformamide and their combination has been tested on human rhabdomyosarcoma RMZ-RC2 clone cells. Ionising radiation at 2-5 Gy doses induced a more differentiated morphology, with the appearance of an increased proportion of multinuclear myotube-like cells, and a significant increase in myosin-positive and multinuclear cells. Radiation appeared to act by inducing de novo differentiated elements. N,N-dimethylformamide was able to induce an increased myosin expression, but did not affect multinuclear cell proportion. The combined treatment (ionising radiation and N,N-dimethylformamide) resulted in an additive increase in the proportion of myosin-positive cells, approaching 25-35%, but de novo differentiated elements were not increased above the levels obtained with irradiation alone.
Differentiation induction therapy has been mainly investigated in leukaemic cells and in rodent solid tumours. In the last decade a few suitable human model systems have been developed (Reiss et al., 1986; Waxman et al., 1988) .
Induction of differentiation has been recently studied in human rhabdomyosarcoma cells. In vitro treatment with retinoic acid (Garvin et al., 1986 ) and phorbol esters (Aguanno et al., 1990) can induce myogenic differentiation; moreover in vivo growth and metastasisation in nude mice were impaired by differentiation induction (Lollini et al., 1991) . We have previously shown that also some (but not all) antineoplastic drugs can induce myogenic differentiation of human rhabdomyosarcoma cells (Lollini et al., 1989) . However in our model system, as in other solid tumours, a complete differentiation was not obtained; the possibility that combined differentiation therapy regimens might be more effective is now being investigated (Wiemann et al., 1988) .
In rodent rhabdomyosarcoma models, differentiation could be induced also by different polar compounds, e.g. N,Ndimethylformamide (Dexter, 1977) and N-methylformamide (Gerharz et al., 1989) . Moreover, these compounds have been reported to enhance radiosensitivity of some human tumour cell cultures (Leith et al., 1982; Leith et al., 1985; Arundel et al., 1987) . The aims of the present work are (a) to analyse the effect in vitro of a common therapeutic approach, radiation therapy, on the differentiation of human rhabdomyosarcoma cells, which are known to be radiosensitive (Kelland et al., 1989) , and (b) to assess whether the combination of ionising radiation with an inducer of differentiation, N,N-dimethylformamide, may lead to an enhancement of myogenic differentiation.
Materials and methods
Cells and standard culture conditions Clone RMZ-RC2, derived from a human alveolar rhabdomyosarcoma and previously characterised (Nanni et al., 1986) , was used between the 20th and the 30th in vitro passages. Cells were routinely maintained in Dulbecco's modified Eagle medium supplemented with 100 U ml-I penicillin, 100i,gml-' streptomycin (hereafter referred to as DMEM) and with 10% foetal calf serum (FCS). All media constituents were purchased from GIBCO, Paisley, Scotland. Cell cultures were incubated at 37°C in a humidified 5% CO2 atmosphere. Cells were monitored for mycoplasma contamination by fluorescent staining with Hoechst 33258 (Chen, 1977) Evaluation of diferentiation Cells were harvested on day 1, 7 and 11, counted and centrifuged at 400 g for 10 min onto glass slides. Cytocentrifuge slides were immediately fixed with methanol:acetone (3:7) at -20°C and stained as described (Nanni et al., 1986) in an indirect immunofluorescence assay with BF-G6 monoclonal antibody recognising embryonic myosin Preliminary experiments with radiation doses up to 10 Gy revealed that y-irradiation induced an increase in the percentage of myosin-positive cells. A plateau level was obtained with doses in excess of 5 Gy. Therefore in this study RMZ-RC2 cells were subjected to 1-5 Gy. The effects of these doses on cell survival are reported in Table I . A significant dose-related increase in myosin expression was observed in RMZ-RC2 cells treated with 2-5 Gy ( Figure  1 ). Induction of differentiation was also evident morphologically, with the appearance of an increased proportion of multinuclear myotube-like cells (Figure 2 ). The percentage of multinuclear myosin-positive cells was also increased (Figure   3 ).
Since a small proportion of myosin-positive and terminallydifferentiated postmitotic cells is always present in RMZ-RC2 cultures (Lollini et al., 1989) , we examined the possibility that the positive effects on differentiation could in some cases be due to a negative selection of proliferating cells. In particular we have shown that some substances can cause an increase in the proportion of differentiated elements through a strong reduction in the number of non-differentiated cells, in the presence of a constant number of differentiated elements. We proposed a parameter called 'de novo differentiation' (Lollini et al., 1989 ) which evaluates both differentiation-inducing and toxic effects of treatment.
Irradiation was able to induce a percentage of de novo differentiation higher than that observed in untreated cultures (Figure 4) , thus indicating that the increase in myosinpositive cells (see Figure 1 ) and in multinuclear myotube-like cells (see Figure 3) was indeed mediated by the induction of myogenic differentiation. It can be noted that the highest percentage of myosin-positive cells did not always correspond to the highest de novo differentiation: the latter showed a peak around 3 Gy, a dose that did not induce a severe reduction in cell survival. At very toxic doses, a decrease in de novo differentiation was observed. When de novo differentiation of multinuclear myosin-positive cells was considered, maximal effect was observed at 4 Gy dose. N,N-dimethylformamide treatment Cell treatment with 0.5% N,N-dimethylformamide induced an increased percentage of myosin-positive cells (20.1 ± 1.6 vs 12.5 ± 0.9). No significant variation in multinuclear cell formation was observed. De novo differentiation of myosinpositive cells, calculated vs parameters of day 7 (i.e. when treatment started), also showed a significant increase in cultures treated with N,N-dimethylformamide (12.7 ± 2.0 vs 6.4 ± 1.4).
Combined treatment
The possibility that a combined treatment with y-irradiation plus N,N-dimethylformamide could result in an enhanced differentiation-inducing effect was tested on 11-day cultures, in which the maximal induction of differentiation by single treatment was previously observed. The combined treatment resulted in an additional 50% increase in myosin expression.
However neither multinuclear cells nor de novo differentiation were further increased above the levels obtained with y-irradiation alone (data not shown).
Discussion
We have shown here that ionising radiation shares with some antineoplastic drugs (Lollini et al., 1989 ) the ability to induce myogenic differentiation of human rhabdomyosarcoma cells. through the determination of the absolute number of differentiated cells and of the 'de novo differentiation' parameter, the possibility that positive effects on differentiation might be due solely to a negative selection of proliferating cells.
Different polar compounds have been reported to induce differentiation in rodent rhabdomyosarcoma cells (Dexter et al., 1977; Gerharz et al., 1989) . In our human model, N,Ndimethylformamide increased the proportion of myosinpositive cells, but no significant variation was observed in the percentage of multinuclear cells, suggesting a mode of induction different from that of y-irradiation. Nmonomethylformamide treatment has been reported to enhance radiosensitivity of some human tumour cell cultures (Arundel et al., 1987 ) and a therapeutic gain was achieved in mice bearing a fibrosarcoma through the combination of NMF and ionising radiation (Iwakawa et al., 1987) .
The differentiation-inducing ability of y-irradiation and N,N-dimethylformamide does not seem to be restricted to the rhabdomyosarcoma model studied: an accelerated appearance of myosin-positive cells was induced in CCA cell line (De Giovanni et al., 1990) derived from an embryonal rhabdomyosarcoma (data not shown).
The combined treatment (irradiation plus N,Ndimethylformamide) resulted, in our model, in an additive effect on the proportion of myosin-positive rhabdomyosarcoma cells. No increase in de novo differentiation was observed, thus suggesting that either the toxic effects caused by the combined treatment prevented the assessment of the effects on differentiation, or a critical step in the pathway to myogenic differentiation reached a plateau after either treatment.
The proportion of myosin-positive elements attained after treatment with ionising radiation or with N,N-dimethylformamide was in the range 25-35%, thus it involved only a minority of cells. Analogous results were obtained also with different substances (Lollini et al., 1989) . It should be noted however that this plateau does not seem to prevent the feasibility of differentiation therapy, since in cultures containing more than 30-40% of differentiated elements we observed a lack of increase in total population cell number, suggesting that the induction of such a proportion of differentiated cells could be enough to significantly alter cell growth. 
